Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
The Impact of Implementation of ICH Guidelines in Non-ICH Countries - Regulatory Support Series No. 009
(2002; 34 pages) Voir le document au format PDF
Table des matières
Afficher le documentExecutive Summary
Afficher le document1. Introduction
Afficher le document2. WHO'S role in developing global standards for pharmaceutical products
Afficher le document3. The International Conference on Harmonisation (ICH)
Afficher le document4. Expanded ICH initiatives
Ouvrir ce répertoire et afficher son contenu5. Implications of the ICH process and globalization of ICH guidelines
Ouvrir ce répertoire et afficher son contenu6. Implication of the use of ICH guidelines by non-ICH drug regulatory authorities
Afficher le document7. WHO guidelines for generic drugs
Afficher le document8. Challenges for WHO
Afficher le document9. Recommendations to WHO
Afficher le documentAnnex I - List of Participants
 

The Impact of Implementation of ICH Guidelines in Non-ICH Countries - Regulatory Support Series No. 009

WHO/EDM/QSM/2002.3
Original: English
Distribution: General

Report of a WHO Meeting
Geneva, 13-15 September 2001

Regulatory Support Series, No. 9

This Series is produced by the WHO Drug Regulatory Support Unit and aims at providing guidance, assistance and training in drug regulatory issues.

The main focus is on supporting the work of national drug regulatory authorities of developing countries.


World Health Organization
Geneva
2002

© World Health Organization 2002

This document is not a formal publication of the World Health Organization (WHO).

All rights are reserved by WHO. The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale or use in conjunction with commercial purposes.

The views expressed in this document reflect the opinions expressed and the discussions that took place during the meeting. These views do not necessarily reflect the decisions or the stated policy of WHO.

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 20 mars 2014